Questions and Answers
What is the classification of Cilostazol?
What is the mechanism of action (MOA) of Cilostazol?
Inhibits PDE3 and increases cAMP, resulting in reduced symptoms of intermittent claudication and increased vasodilation.
What are the adverse effects of Cilostazol?
Tachycardia and heart palpitations
What nursing interventions should be taken when administering Cilostazol?
Signup and view all the answers
Which of the following are other platelet medications? (Select all that apply)
Signup and view all the answers
Study Notes
Cilostazol Classification
- Classified as a platelet aggregation inhibitor.
Mechanism of Action (MOA)
- Inhibits phosphodiesterase type 3 (PDE3), leading to increased cyclic AMP (cAMP) levels.
- Reduces symptoms of intermittent claudication by improving walking distance and alleviating leg cramps.
- Promotes vasodilation, enhancing blood flow.
Adverse Effects
- Common side effects include tachycardia (increased heart rate) and heart palpitations.
Nursing Interventions
- Administer cilostazol on an empty stomach, ideally 1 to 2 hours before or after meals.
- Exercise caution when prescribing to patients with heart disease due to potential cardiovascular effects.
Other Platelet Medications
- Pentoxifylline: Used to improve blood flow in peripheral vascular disease.
- Heparin: Anticoagulant that prevents blood clots.
- Clopidogrel: Antiplatelet agent that inhibits platelet aggregation to reduce the risk of cardiovascular events.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Description
Test your knowledge on cilostazol, its mechanism of action, and nursing interventions related to its use. This quiz also covers common side effects and comparisons with other platelet medications like pentoxifylline and clopidogrel. Perfect for nursing students and healthcare professionals!
